img

Global Naloxegol Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Naloxegol Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Naloxegol report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Naloxegol market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Pharmacy and Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Naloxegol industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Naloxegol key companies include MOVANTIK, AstraZeneca, Aurobindo, MSN Life Sciences, Lepu, Daiichi Sankyo Company, Knight Therapeutics, Kyowa Kirin International and Nektar Therapeutics, etc. MOVANTIK, AstraZeneca, Aurobindo are top 3 players and held % share in total in 2022.
Naloxegol can be divided into Tablet and Capsule, etc. Tablet is the mainstream product in the market, accounting for % share globally in 2022.
Naloxegol is widely used in various fields, such as Pharmacy, Hospital, Clinic and Others, etc. Pharmacy provides greatest supports to the Naloxegol industry development. In 2022, global % share of Naloxegol went into Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Naloxegol market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


MOVANTIK
AstraZeneca
Aurobindo
MSN Life Sciences
Lepu
Daiichi Sankyo Company
Knight Therapeutics
Kyowa Kirin International
Nektar Therapeutics
RedHill Biopharma Ltd.
Segment by Type
Tablet
Capsule

Segment by Application


Pharmacy
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Naloxegol market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Naloxegol introduction, etc. Naloxegol Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Naloxegol market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Naloxegol
1.1 Naloxegol Market Overview
1.1.1 Naloxegol Product Scope
1.1.2 Naloxegol Market Status and Outlook
1.2 Global Naloxegol Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Naloxegol Market Size by Region (2024-2034)
1.4 Global Naloxegol Historic Market Size by Region (2024-2024)
1.5 Global Naloxegol Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Naloxegol Market Size (2024-2034)
1.6.1 North America Naloxegol Market Size (2024-2034)
1.6.2 Europe Naloxegol Market Size (2024-2034)
1.6.3 Asia-Pacific Naloxegol Market Size (2024-2034)
1.6.4 Latin America Naloxegol Market Size (2024-2034)
1.6.5 Middle East & Africa Naloxegol Market Size (2024-2034)
2 Naloxegol Market by Type
2.1 Introduction
2.1.1 Tablet
2.1.2 Capsule
2.2 Global Naloxegol Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Naloxegol Historic Market Size by Type (2024-2024)
2.2.2 Global Naloxegol Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Naloxegol Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Naloxegol Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Naloxegol Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Naloxegol Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Naloxegol Revenue Breakdown by Type (2024-2034)
3 Naloxegol Market Overview by Application
3.1 Introduction
3.1.1 Pharmacy
3.1.2 Hospital
3.1.3 Clinic
3.1.4 Others
3.2 Global Naloxegol Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Naloxegol Historic Market Size by Application (2024-2024)
3.2.2 Global Naloxegol Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Naloxegol Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Naloxegol Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Naloxegol Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Naloxegol Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Naloxegol Revenue Breakdown by Application (2024-2034)
4 Naloxegol Competition Analysis by Players
4.1 Global Naloxegol Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Naloxegol as of 2022)
4.3 Date of Key Players Enter into Naloxegol Market
4.4 Global Top Players Naloxegol Headquarters and Area Served
4.5 Key Players Naloxegol Product Solution and Service
4.6 Competitive Status
4.6.1 Naloxegol Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 MOVANTIK
5.1.1 MOVANTIK Profile
5.1.2 MOVANTIK Main Business
5.1.3 MOVANTIK Naloxegol Products, Services and Solutions
5.1.4 MOVANTIK Naloxegol Revenue (US$ Million) & (2024-2024)
5.1.5 MOVANTIK Recent Developments
5.2 AstraZeneca
5.2.1 AstraZeneca Profile
5.2.2 AstraZeneca Main Business
5.2.3 AstraZeneca Naloxegol Products, Services and Solutions
5.2.4 AstraZeneca Naloxegol Revenue (US$ Million) & (2024-2024)
5.2.5 AstraZeneca Recent Developments
5.3 Aurobindo
5.3.1 Aurobindo Profile
5.3.2 Aurobindo Main Business
5.3.3 Aurobindo Naloxegol Products, Services and Solutions
5.3.4 Aurobindo Naloxegol Revenue (US$ Million) & (2024-2024)
5.3.5 MSN Life Sciences Recent Developments
5.4 MSN Life Sciences
5.4.1 MSN Life Sciences Profile
5.4.2 MSN Life Sciences Main Business
5.4.3 MSN Life Sciences Naloxegol Products, Services and Solutions
5.4.4 MSN Life Sciences Naloxegol Revenue (US$ Million) & (2024-2024)
5.4.5 MSN Life Sciences Recent Developments
5.5 Lepu
5.5.1 Lepu Profile
5.5.2 Lepu Main Business
5.5.3 Lepu Naloxegol Products, Services and Solutions
5.5.4 Lepu Naloxegol Revenue (US$ Million) & (2024-2024)
5.5.5 Lepu Recent Developments
5.6 Daiichi Sankyo Company
5.6.1 Daiichi Sankyo Company Profile
5.6.2 Daiichi Sankyo Company Main Business
5.6.3 Daiichi Sankyo Company Naloxegol Products, Services and Solutions
5.6.4 Daiichi Sankyo Company Naloxegol Revenue (US$ Million) & (2024-2024)
5.6.5 Daiichi Sankyo Company Recent Developments
5.7 Knight Therapeutics
5.7.1 Knight Therapeutics Profile
5.7.2 Knight Therapeutics Main Business
5.7.3 Knight Therapeutics Naloxegol Products, Services and Solutions
5.7.4 Knight Therapeutics Naloxegol Revenue (US$ Million) & (2024-2024)
5.7.5 Knight Therapeutics Recent Developments
5.8 Kyowa Kirin International
5.8.1 Kyowa Kirin International Profile
5.8.2 Kyowa Kirin International Main Business
5.8.3 Kyowa Kirin International Naloxegol Products, Services and Solutions
5.8.4 Kyowa Kirin International Naloxegol Revenue (US$ Million) & (2024-2024)
5.8.5 Kyowa Kirin International Recent Developments
5.9 Nektar Therapeutics
5.9.1 Nektar Therapeutics Profile
5.9.2 Nektar Therapeutics Main Business
5.9.3 Nektar Therapeutics Naloxegol Products, Services and Solutions
5.9.4 Nektar Therapeutics Naloxegol Revenue (US$ Million) & (2024-2024)
5.9.5 Nektar Therapeutics Recent Developments
5.10 RedHill Biopharma Ltd.
5.10.1 RedHill Biopharma Ltd. Profile
5.10.2 RedHill Biopharma Ltd. Main Business
5.10.3 RedHill Biopharma Ltd. Naloxegol Products, Services and Solutions
5.10.4 RedHill Biopharma Ltd. Naloxegol Revenue (US$ Million) & (2024-2024)
5.10.5 RedHill Biopharma Ltd. Recent Developments
6 North America
6.1 North America Naloxegol Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Naloxegol Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Naloxegol Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Naloxegol Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Naloxegol Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Naloxegol Market Dynamics
11.1 Naloxegol Industry Trends
11.2 Naloxegol Market Drivers
11.3 Naloxegol Market Challenges
11.4 Naloxegol Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Naloxegol Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Naloxegol Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Naloxegol Market Size Share by Region (2024-2024)
Table 4. Global Naloxegol Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Naloxegol Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Naloxegol Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Naloxegol Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Naloxegol Revenue Market Share by Type (2024-2024)
Table 9. Global Naloxegol Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Naloxegol Revenue Market Share by Type (2024-2034)
Table 11. North America Naloxegol Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Naloxegol Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Naloxegol Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Naloxegol Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Naloxegol Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Naloxegol Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Naloxegol Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Naloxegol Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Naloxegol Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Naloxegol Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Naloxegol Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Naloxegol Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Naloxegol Revenue Market Share by Application (2024-2024)
Table 24. Global Naloxegol Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Naloxegol Revenue Market Share by Application (2024-2034)
Table 26. North America Naloxegol Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Naloxegol Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Naloxegol Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Naloxegol Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Naloxegol Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Naloxegol Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Naloxegol Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Naloxegol Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Naloxegol Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Naloxegol Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Naloxegol Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Naloxegol Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Naloxegol as of 2022)
Table 39. Date of Key Players Enter into Naloxegol Market
Table 40. Global Naloxegol Key Players Headquarters and Area Served
Table 41. Naloxegol Product Solution and Service
Table 42. Global Naloxegol Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. MOVANTIK Basic Information List
Table 45. MOVANTIK Description and Business Overview
Table 46. MOVANTIK Naloxegol Products, Services and Solutions
Table 47. Revenue (US$ Million) in Naloxegol Business of MOVANTIK (2024-2024)
Table 48. MOVANTIK Recent Developments
Table 49. AstraZeneca Basic Information List
Table 50. AstraZeneca Description and Business Overview
Table 51. AstraZeneca Naloxegol Products, Services and Solutions
Table 52. Revenue (US$ Million) in Naloxegol Business of AstraZeneca (2024-2024)
Table 53. AstraZeneca Recent Developments
Table 54. Aurobindo Basic Information List
Table 55. Aurobindo Description and Business Overview
Table 56. Aurobindo Naloxegol Products, Services and Solutions
Table 57. Revenue (US$ Million) in Naloxegol Business of Aurobindo (2024-2024)
Table 58. Aurobindo Recent Developments
Table 59. MSN Life Sciences Basic Information List
Table 60. MSN Life Sciences Description and Business Overview
Table 61. MSN Life Sciences Naloxegol Products, Services and Solutions
Table 62. Revenue (US$ Million) in Naloxegol Business of MSN Life Sciences (2024-2024)
Table 63. MSN Life Sciences Recent Developments
Table 64. Lepu Basic Information List
Table 65. Lepu Description and Business Overview
Table 66. Lepu Naloxegol Products, Services and Solutions
Table 67. Revenue (US$ Million) in Naloxegol Business of Lepu (2024-2024)
Table 68. Lepu Recent Developments
Table 69. Daiichi Sankyo Company Basic Information List
Table 70. Daiichi Sankyo Company Description and Business Overview
Table 71. Daiichi Sankyo Company Naloxegol Products, Services and Solutions
Table 72. Revenue (US$ Million) in Naloxegol Business of Daiichi Sankyo Company (2024-2024)
Table 73. Daiichi Sankyo Company Recent Developments
Table 74. Knight Therapeutics Basic Information List
Table 75. Knight Therapeutics Description and Business Overview
Table 76. Knight Therapeutics Naloxegol Products, Services and Solutions
Table 77. Revenue (US$ Million) in Naloxegol Business of Knight Therapeutics (2024-2024)
Table 78. Knight Therapeutics Recent Developments
Table 79. Kyowa Kirin International Basic Information List
Table 80. Kyowa Kirin International Description and Business Overview
Table 81. Kyowa Kirin International Naloxegol Products, Services and Solutions
Table 82. Revenue (US$ Million) in Naloxegol Business of Kyowa Kirin International (2024-2024)
Table 83. Kyowa Kirin International Recent Developments
Table 84. Nektar Therapeutics Basic Information List
Table 85. Nektar Therapeutics Description and Business Overview
Table 86. Nektar Therapeutics Naloxegol Products, Services and Solutions
Table 87. Revenue (US$ Million) in Naloxegol Business of Nektar Therapeutics (2024-2024)
Table 88. Nektar Therapeutics Recent Developments
Table 89. RedHill Biopharma Ltd. Basic Information List
Table 90. RedHill Biopharma Ltd. Description and Business Overview
Table 91. RedHill Biopharma Ltd. Naloxegol Products, Services and Solutions
Table 92. Revenue (US$ Million) in Naloxegol Business of RedHill Biopharma Ltd. (2024-2024)
Table 93. RedHill Biopharma Ltd. Recent Developments
Table 94. North America Naloxegol Market Size by Country (2024-2024) & (US$ Million)
Table 95. North America Naloxegol Market Size by Country (2024-2034) & (US$ Million)
Table 96. Europe Naloxegol Market Size by Country (2024-2024) & (US$ Million)
Table 97. Europe Naloxegol Market Size by Country (2024-2034) & (US$ Million)
Table 98. Asia-Pacific Naloxegol Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 99. Asia-Pacific Naloxegol Market Size by Region (2024-2024) & (US$ Million)
Table 100. Asia-Pacific Naloxegol Market Size by Region (2024-2034) & (US$ Million)
Table 101. Asia-Pacific Naloxegol Market Share by Region (2024-2024)
Table 102. Asia-Pacific Naloxegol Market Share by Region (2024-2034)
Table 103. Latin America Naloxegol Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 104. Latin America Naloxegol Market Size by Country (2024-2024) & (US$ Million)
Table 105. Latin America Naloxegol Market Size by Country (2024-2034) & (US$ Million)
Table 106. Middle East & Africa Naloxegol Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 107. Middle East & Africa Naloxegol Market Size by Country (2024-2024) & (US$ Million)
Table 108. Middle East & Africa Naloxegol Market Size by Country (2024-2034) & (US$ Million)
Table 109. Naloxegol Market Trends
Table 110. Naloxegol Market Drivers
Table 111. Naloxegol Market Challenges
Table 112. Naloxegol Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Naloxegol Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Naloxegol Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Naloxegol Market Share by Regions: 2022 VS 2034
Figure 4. Global Naloxegol Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Naloxegol Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Naloxegol Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Naloxegol Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Naloxegol Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Naloxegol Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Tablet
Figure 11. Global Tablet Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Capsule
Figure 13. Global Capsule Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global Naloxegol Market Size Share by Type: 2022 & 2034
Figure 15. North America Naloxegol Revenue Market Share by Type (2024-2034)
Figure 16. Europe Naloxegol Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific Naloxegol Revenue Market Share by Type (2024-2034)
Figure 18. Latin America Naloxegol Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa Naloxegol Revenue Market Share by Type (2024-2034)
Figure 20. Pharmacy Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. Hospital Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Clinic Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Global Naloxegol Market Size Share by Application: 2022 & 2034
Figure 25. North America Naloxegol Revenue Market Share by Application (2024-2034)
Figure 26. Europe Naloxegol Revenue Market Share by Application (2024-2034)
Figure 27. Asia-Pacific Naloxegol Revenue Market Share by Application (2024-2034)
Figure 28. Latin America Naloxegol Revenue Market Share by Application (2024-2034)
Figure 29. Middle East and Africa Naloxegol Revenue Market Share by Application (2024-2034)
Figure 30. Naloxegol Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 31. Global Top 5 and Top 10 Players Naloxegol Market Share in 2022
Figure 32. North America Naloxegol Market Share by Country (2024-2034)
Figure 33. United States Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 34. Canada Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 35. Germany Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 36. France Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 37. U.K. Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 38. Italy Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 39. Russia Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 40. Nordic Countries Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 41. Asia-Pacific Naloxegol Market Share by Region (2024-2034)
Figure 42. China Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 43. Japan Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 44. South Korea Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 45. Southeast Asia Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 46. India Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 47. Australia Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 48. Latin America Naloxegol Market Share by Country (2024-2034)
Figure 49. Mexico Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 50. Brazil Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 51. Middle East & Africa Naloxegol Market Share by Country (2024-2034)
Figure 52. Turkey Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 54. UAE Naloxegol Market Size (2024-2034) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report